- Home
- ZBAO vs COEP Comparison
ZBAO vs COEP Comparison
Compare ZBAO & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBAO
- COEP
- Stock Information
- Founded
- ZBAO 2015
- COEP 2017
- Country
- ZBAO China
- COEP United States
- Employees
- ZBAO N/A
- COEP N/A
- Industry
- ZBAO
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZBAO
- COEP Health Care
- Exchange
- ZBAO NYSE
- COEP Nasdaq
- Market Cap
- ZBAO 36.2M
- COEP 30.5M
- IPO Year
- ZBAO 2024
- COEP N/A
- Fundamental
- Price
- ZBAO $1.31
- COEP $11.50
- Analyst Decision
- ZBAO
- COEP
- Analyst Count
- ZBAO 0
- COEP 0
- Target Price
- ZBAO N/A
- COEP N/A
- AVG Volume (30 Days)
- ZBAO 498.7K
- COEP 25.5K
- Earning Date
- ZBAO 04-15-2025
- COEP 05-09-2025
- Dividend Yield
- ZBAO N/A
- COEP N/A
- EPS Growth
- ZBAO N/A
- COEP N/A
- EPS
- ZBAO 0.09
- COEP N/A
- Revenue
- ZBAO $33,673,520.00
- COEP N/A
- Revenue This Year
- ZBAO $65.08
- COEP N/A
- Revenue Next Year
- ZBAO $34.27
- COEP N/A
- P/E Ratio
- ZBAO $11.61
- COEP N/A
- Revenue Growth
- ZBAO 82.66
- COEP N/A
- 52 Week Low
- ZBAO $0.85
- COEP $2.31
- 52 Week High
- ZBAO $5.70
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- ZBAO N/A
- COEP 68.30
- Support Level
- ZBAO N/A
- COEP $9.16
- Resistance Level
- ZBAO N/A
- COEP $11.69
- Average True Range (ATR)
- ZBAO 0.00
- COEP 0.52
- MACD
- ZBAO 0.00
- COEP 0.29
- Stochastic Oscillator
- ZBAO 0.00
- COEP 92.82
About ZBAO ZHIBAO TECHNOLOGY INC
Zhibao Technology Inc is a insurance technology company engaged in providing digital insurance brokerage services in China. 2B2C digital embedded insurance is their business model which is pioneered in China. It provides customized digital insurance solutions for B-side channels (covering a wide range of industries and organizations, including but not limited to Internet platforms, large and medium-sized enterprises, and government agencies, etc.), embedding them into the channel's existing business matrix, and providing the channel with Provide digital insurance brokerage services to C-end customers.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.